Literature DB >> 2065325

Maternal and perinatal risk factors for childhood leukemia.

M Zack1, H O Adami, A Ericson.   

Abstract

This report describes an exploratory population-based study of maternal and perinatal risk factors for childhood leukemia in Sweden. The Swedish National Cancer Registry ascertained 411 cases in successive birth cohorts from 1973 through 1984 recorded in the Swedish Medical Birth Registry. Using the latter, we matched five controls without cancer to each case by sex and month and year of birth. Mothers of children with leukemia were more likely to have been exposed to nitrous oxide anesthesia during delivery than mothers of controls [odds ratio (OR) = 1.3; 95% confidence interval (CI) = 1.0, 1.6]. Children with leukemia were more likely than controls to have Down's syndrome (OR = 32.5; 95% CI = 7.3, 144.0) or cleft lip or cleft palate (OR = 5.0; 95% CI = 1.0, 24.8); to have had a diagnosis associated with difficult labor but unspecified complications (OR = 4.5; 95% CI = 1.1, 18.2) or with other conditions of the fetus or newborn (OR = 1.5; 95% CI = 1.1, 2.1), specifically, uncomplicated physiological jaundice (OR = 1.9; 95% CI = 1.2, 2.9); or to have received supplemental oxygen (OR = 2.6; 95% CI = 1.3, 1.3, 4.9). Because multiple potential risk factors were analyzed in this study, future studies need to check these findings. We did not confirm the previously reported higher risks for childhood leukemia associated with being male, having a high birth weight, or being born to a woman of advanced maternal age.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2065325

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  30 in total

1.  Childhood leukemia and social circumstance.

Authors:  G Wyllie
Journal:  Cancer Causes Control       Date:  1996-03       Impact factor: 2.506

2.  Infant leukemia and congenital abnormalities: a Children's Oncology Group study.

Authors:  Kimberly J Johnson; Michelle A Roesler; Amy M Linabery; Joanne M Hilden; Stella M Davies; Julie A Ross
Journal:  Pediatr Blood Cancer       Date:  2010-07-15       Impact factor: 3.167

3.  Risk of breast cancer in families with cleft lip and palate.

Authors:  Alexander Dietz; Dorthe Almind Pedersen; Rune Jacobsen; George L Wehby; Jeffrey C Murray; Kaare Christensen
Journal:  Ann Epidemiol       Date:  2011-10-28       Impact factor: 3.797

4.  Cancer risk in persons with oral cleft--a population-based study of 8,093 cases.

Authors:  Camilla Bille; Jeanette Falck Winther; Andrea Bautz; Jeffrey C Murray; Jørn Olsen; Kaare Christensen
Journal:  Am J Epidemiol       Date:  2005-06-01       Impact factor: 4.897

Review 5.  Major histocompatibility complex, t-complex, and leukemia.

Authors:  M T Dorak; A K Burnett
Journal:  Cancer Causes Control       Date:  1992-05       Impact factor: 2.506

6.  Maternal and perinatal risk factors for childhood brain tumors (Sweden).

Authors:  M S Linet; G Gridley; S Cnattingius; H S Nicholson; U Martinsson; B Glimelius; H O Adami; M Zack
Journal:  Cancer Causes Control       Date:  1996-07       Impact factor: 2.506

7.  Congenital abnormalities and acute leukemia among children with Down syndrome: a Children's Oncology Group study.

Authors:  Amy M Linabery; Cindy K Blair; Alan S Gamis; Andrew F Olshan; Nyla A Heerema; Julie A Ross
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-09-30       Impact factor: 4.254

8.  Long term follow up study of survival associated with cleft lip and palate at birth.

Authors:  Kaare Christensen; Knud Juel; Anne Maria Herskind; Jeffrey C Murray
Journal:  BMJ       Date:  2004-05-14

9.  Administration of vitamin K to newborn infants and childhood cancer.

Authors:  H Ekelund; O Finnström; J Gunnarskog; B Källén; Y Larsson
Journal:  BMJ       Date:  1993-07-10

10.  Comparison of birth weight corrected for gestational age and birth weight alone in prediction of development of childhood leukemia and central nervous system tumors.

Authors:  Michael R Sprehe; Nadia Barahmani; Yumei Cao; Tao Wang; Michele R Forman; Melissa Bondy; M Fatih Okcu
Journal:  Pediatr Blood Cancer       Date:  2010-02       Impact factor: 3.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.